Huifeng Jia

机构：Hua Medicine (China)

发表论文 8 篇 · 总被引 123 次 · h-index 5

代表论文

• A Novel Bispecific Antibody Targeting PD-L1 and VEGF With Combined Anti-Tumor Activities (2021 · Frontiers in Immunology · 被引 58)
• Homeobox containing�1 inhibits liver cancer progression by promoting autophagy as well as inhibiting stemness and immune escape (2018 · Oncology Reports · 被引 23)
• A novel engineered VEGF blocker with an excellent pharmacokinetic profile and robust anti-tumor activity (2015 · BMC Cancer · 被引 19)
• Structural and functional insights into a novel pre-clinical-stage antibody targeting IL-17A for treatment of autoimmune diseases (2022 · International Journal of Biological Macromolecules · 被引 11)
• An antibody cocktail targeting two different CD73 epitopes enhances enzyme inhibition and tumor control (2024 · Nature Communications · 被引 9)
• Dual blockade of IL-17A and IL-36 pathways via a bispecific antibody exhibits enhanced anti-inflammatory potency (2024 · Frontiers in Immunology · 被引 4)